NeuroFed - Neurological Stimulation and Modulation Devices
  • Sign In
  • Create Account

  • My Account
  • Signed in as:
  • filler@godaddy.com

  • My Account
  • Sign out
NeuroFed - Neurological Stimulation and Modulation Devices
  • Home
  • Devices
  • Neurological Device Info
    • Mechanism of Action
    • The IB-Stim
    • The Bridge
    • NSS - Military Field Stim
    • IB-Stim Downloads
    • Bridge Downloads
    • NSS/MFS Downloads
  • Neuro Research
    • Neurostimulation Research
    • Neuromodulation Research
    • Opioid Addiction Research
    • Neurostim for Opioid Use
  • FDA Indications
  • About NeuroFed
    • About Us
    • Contact Us
  • More
    • Home
    • Devices
    • Neurological Device Info
      • Mechanism of Action
      • The IB-Stim
      • The Bridge
      • NSS - Military Field Stim
      • IB-Stim Downloads
      • Bridge Downloads
      • NSS/MFS Downloads
    • Neuro Research
      • Neurostimulation Research
      • Neuromodulation Research
      • Opioid Addiction Research
      • Neurostim for Opioid Use
    • FDA Indications
    • About NeuroFed
      • About Us
      • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:
  • filler@godaddy.com

  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Devices
  • Neurological Device Info
  • Neuro Research
  • FDA Indications
  • About NeuroFed

Account


  • My Account
  • Sign out

  • Sign In
  • My Account

The Bridge - for the treamtent of opioid withdrawal symptom

FDA Cleared Percutaneous Neurological Field Stimulator

88% of Patients Successfully Transitioned to Medication Assisted Treatment

88% of Patients Successfully Transitioned to Medication Assisted Treatment

image841

The bridge is a non-surgical and non-pharmacological option for treating the symptoms of opioid withdrawal at the brain. In November of 2017 the FDA cleared the Bridge for the treatment of the symptoms of opioid withdrawal. FDA gave this indication via the DeNovo process which is the most rigorous FDA process for a type II medical device and it is based not only on safety, but efficacy as well. 

88% of Patients Successfully Transitioned to Medication Assisted Treatment

88% of Patients Successfully Transitioned to Medication Assisted Treatment

88% of Patients Successfully Transitioned to Medication Assisted Treatment

image842

Results:

  • 62.7% Reduction in C.O.W.S. after 30 Minutes
  • 84.6% Reduction in C.O.W.S after 1 Hour
  • 97.1% Reduction in C.O.W.S after 5 days
  • 88.8% Successfule transition to M.A.T. after 5 days


Download Bridge Douments

Sign up as a member to receive access to all of our downloadable files regarding the Bridge. This information will not be sold to third parties or be used to market GAN Inc's services to our members

Download today
  • The IB-Stim
  • The Bridge
  • NSS - Military Field Stim
  • Privacy Policy
  • Terms And Conditions
  • linkconnector.htm

NeuroFed - Neurological Stimulation Devices

Graham Advisory Network Inc. Raleigh NC and Wilkes-Barre PA

‪(919) 480-2072

Copyright © 2019 Graham Advisory Network Inc. - All Rights Reserved.

GANInc